The mitroflow pericardial valve. First results of a follow-up study.
One hundred eighty-eight Mitroflow pericardial valves, implanted on 166 patients from March 1983 to December 1986, have been followed for a total of 4316 patients x months. Mortality rate in the first three postoperative months is approximately 10% related to noncardiac complications. One hundred forty-nine patients are living at the start of the follow up period. During that period, one valve was explanted after 22 months for a cusp tear. The rate of thrombo embolic episode is minimal, six cases, as 47% are free of any anticoagulant therapy. One patient, operated upon for active SBE, required additional surgery 2 months later for a prosthetic infection. The present results suggest that early primary failure of Mitroflow valve is quite unfrequent.
Loisance
D
D
Department of Cardiac Surgery, C.H.U. Henri Mondor, Créteil, France.
Hillion
M L
ML
Cachera
J P
JP
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001021:Aortic Valve / Q000601:surgery; D001705:Bioprosthesis; D002423:Cause of Death; D005260:Female; D005500:Follow-Up Studies; D006349:Heart Valve Diseases / Q000601:surgery*; D006350:Heart Valve Prosthesis; D006801:Humans; D008297:Male; D008875:Middle Aged; D008943:Mitral Valve / Q000601:surgery; D011183:Postoperative Complications / Q000401:mortality; D011475:Prosthesis Failure; D014261:Tricuspid Valve / Q000601:surgery